Yale’s Post ASH Review: Highlights from the 2024 American Society of Hematology Annual Meeting

This meeting will highlight key takeaways from the 2024 ASH Symposium, tailored specifically for hematologists, oncologists, primary care physicians, pathologists, fellows in hematology/oncology, oncology nurses, oncology social workers, and other healthcare professionals involved in blood cancer treatment. The program offers a comprehensive review of the latest research developments in hematologic malignancies from the past year, with a focus on their real-world applications in patient care.

1. Describe the current treatment options and updates in various lymphoma, multiple myeloma, leukemia, and myeloid malignancies.
2. Discuss the development and outcomes of clinical research trials, cellular therapies, and transplant options for hematological malignancies and assess their relevance to patient care
3. Assess the emerging role of immunotherapy, targeted therapies, cellular therapies and antibodies in hematological malignancies
4. Review updates in classical hematology, including bleeding disorders and thrombosis

Registration is complimentary; however, we require you to register to account for seating and meals.

If you have any questions, please contact the Center for Continuing Medical Education at [email protected].

Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement
Yale School of Medicine approves this live activity for 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC POINTS ~ Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 6.25 Medical Knowledge Only MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Part II program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Financial Statement
The Yale School of Medicine and Yale Cancer Center are grateful to their supporters. They are acknowledged in all conference materials. 

This symposium is being held at Anthony's Ocean View, located at 450 Lighthouse Rd, New Haven, CT 06512. Free on-site parking is available. 

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Renee Gaudette
Yale Cancer Center
New Haven, CT

Activity Administrator

Non-Clinical Exception

Natalia Neparidze, MD, Associate Professor
Assistant Professor (Hematology)
Yale School of Medicine
Fairfield, CT

Course Director, Faculty

Grant or research support-GlaxoSmithKline|Grant or research support-Janssen

Jennifer Afranie-Sakyi, MD
Clinical Fellow
Yale School of Medicine
New Haven , CT

Faculty

Nothing to disclose

Jan Bewersdorf, MD
New Yale Faculty Recruit
Yale School of Medicine
New Haven, CT

Faculty

Nothing to disclose

Sabrina L Browning, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
Milford, CT

Faculty

Grant or research support-Janssen

Eric Chang, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Nothing to disclose

Talib Dosani, MD
Yale University
New Haven, CT

Faculty

Nothing to disclose

Elan Gorshein, MD
Smilow Cancer Center
Westport, CT

Faculty

Advisor-Janssen|Advisor-Abbvie

Lohith Gowda, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Consulting Fee-Bristol Myers Squibb (Relationship has ended)

Scott Huntington, MD, MPH, MSc
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Consulting Fee-Abbvie|Consulting Fee-Epizyme (Relationship has ended)|Consulting Fee-Pfizer (Relationship has ended)|Consulting Fee-TG Therapuetics (Relationship has ended)|Consulting Fee-ADC Therapuetics (Relationship has ended)|Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Genentech|Consulting Fee-Janssen|Consulting Fee-Merck|Consulting Fee-Servier (Relationship has ended)|Consulting Fee-Tyme Inc (Relationship has ended)|Consulting Fee-Arvinas|Consulting Fee-BeiGene (Relationship has ended)

Iris Isufi, MD
Associate Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Advisor-Genmab (Relationship has ended)|Advisor-Incyte (Relationship has ended)|Advisor-ADC Therapeutics (Relationship has ended)|Advisor-Bristol Myers Squibb|Advisor-Janssen|Speakers Bureau-Gilead (Relationship has ended)

Shalin Kothari, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Kelsey Martin, MD
Assistant Professor of Clinical Medicine (Hematology)
Yale School of Medicine
Westport, CT

Faculty

Nothing to disclose

Lourdes Mendez, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Consulting Fee-Rigel (Relationship has ended)|Consulting Fee-Inventiva (Relationship has ended)

Terri Parker, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Nothing to disclose

Alexander Pine, MD PHD
assistant professor
Yale school of medicine/VA Connecticut
Branford, CT

Faculty

Nikolai Podoltsev, MD, PhD
Yale School of Medicine
New Haven, CT

Faculty

Honoraria-Blueprint Medicines (Relationship has ended)|Honoraria-MorphoSys (Relationship has ended)|Honoraria-Novartis (Relationship has ended)|Honoraria-Sobi (Relationship has ended)|Honoraria-Aptose Biosciences (Relationship has ended)|Honoraria-Abbvie (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cogent biosciences |Membership on Advisory Committees or Review Panels, Board Membership, etc.-Karyopharm|Honoraria-Syndax (Relationship has ended)|Honoraria-Incyte (Relationship has ended)

Allison Rentfro, MD, PhD
Yale School of Medicine
New Haven, CT

Faculty

Nothing to disclose

Justine Ryu, MD
Assistant Professor of Medicine (Hematology)
Yale School of Medicine
New Haven, CT

Faculty

Stuart Seropian, MD
Hematology
New haven

Faculty

Nothing to disclose

Tarsheen Sethi, MD
Assistant Professor of Medicine
Yale School of Medicine (Hematology)
New Haven, CT

Faculty

Nothing to disclose

Edward Stadtmauer, MD
Professor of Medicine, Director, Hematologic Malignancies Clinical/Translational Research
University of Pennsylvania
Philadelphia, PA

Faculty

Grant or research support-AstraZeneca|Consulting Fee-Bristol Myers Squibb

Maximilian Stahl, MD
Director of Leukemia Program
Yale School of Medicine
New Haven, CT

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol Myers Squibb (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-GlaxoSmithKline (Relationship has ended)

Friday, March 28, 2025